Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.
Gibert J, Clavé S, Hardy-Werbin M, Taus Á, Rocha P, Longarón R, Piquer G, Chaib I, Carcereny E, Morán T, Salido M, Dalmases A, Bellosillo B, Arriola E. Gibert J, et al. Lung Cancer. 2020 Feb;140:42-45. doi: 10.1016/j.lungcan.2019.12.003. Epub 2019 Dec 5. Lung Cancer. 2020. PMID: 31862576
Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.
Garcia-Gisbert N, Camacho L, Fernández-Ibarrondo L, Fernández-Rodriguez C, Longarón R, Gibert J, Angona A, Andrade-Campos M, Salar A, Besses C, Bellosillo B. Garcia-Gisbert N, et al. Among authors: gibert j. Br J Haematol. 2020 Jun;189(5):e204-e207. doi: 10.1111/bjh.16624. Epub 2020 Mar 31. Br J Haematol. 2020. PMID: 32232981 Free article. No abstract available.
Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms.
Garcia-Gisbert N, Fernández-Ibarrondo L, Fernández-Rodríguez C, Gibert J, Andrade-Campos M, Arenillas L, Camacho L, Angona A, Longarón R, Salar A, Calvo X, Besses C, Bellosillo B. Garcia-Gisbert N, et al. Among authors: gibert j. Br J Haematol. 2021 Jan;192(2):300-309. doi: 10.1111/bjh.17087. Epub 2020 Sep 18. Br J Haematol. 2021. PMID: 32945548 Free article.
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
Calvo X, Garcia-Gisbert N, Parraga I, Gibert J, Florensa L, Andrade-Campos M, Merchan B, Garcia-Avila S, Montesdeoca S, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Roman-Bravo D, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: gibert j. Blood Adv. 2020 Oct 27;4(20):5285-5296. doi: 10.1182/bloodadvances.2020002206. Blood Adv. 2020. PMID: 33108455 Free PMC article.
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC.
Rocha P, Ramal D, Ripoll E, Moliner L, Corbera A, Hardy-Werbin M, Orrillo M, Taus Á, Zuccarino F, Gibert J, Perera-Bel J, Casadevall D, Arriola E. Rocha P, et al. Among authors: gibert j. JTO Clin Res Rep. 2020 Oct 28;2(1):100115. doi: 10.1016/j.jtocrr.2020.100115. eCollection 2021 Jan. JTO Clin Res Rep. 2020. PMID: 34589976 Free PMC article.
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.
Fernández-Rodríguez C, Rodríguez-Sevilla JJ, Fernández-Ibarrondo L, Sánchez-González B, Gibert J, Bento L, García JF, Sancho JM, Diez-Feijóo R, Camacho L, García-Retortillo M, Gimeno E, Colomo L, Gutiérrez A, Bellosillo B, Salar A. Fernández-Rodríguez C, et al. Among authors: gibert j. Blood Adv. 2022 Jan 11;6(1):82-86. doi: 10.1182/bloodadvances.2021005316. Blood Adv. 2022. PMID: 34649275 Free PMC article.
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
Garcia-Gisbert N, Garcia-Ávila S, Merchán B, Salido M, Fernández-Rodríguez C, Gibert J, Fernández-Ibarrondo L, Camacho L, Lafuente M, Longarón R, Espinet B, Vélez P, Pujol RM, Andrade-Campos M, Arenillas L, Salar A, Calvo X, Besses C, Bellosillo B. Garcia-Gisbert N, et al. Among authors: gibert j. Blood Adv. 2022 May 24;6(10):3178-3188. doi: 10.1182/bloodadvances.2021006565. Blood Adv. 2022. PMID: 35192693 Free PMC article.
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.
Calvo X, Roman-Bravo D, Garcia-Gisbert N, Rodriguez-Sevilla JJ, Garcia-Avila S, Florensa L, Gibert J, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Bellosillo B, Ferrer A, Arenillas L. Calvo X, et al. Among authors: gibert j. Blood Adv. 2022 Jul 12;6(13):3921-3931. doi: 10.1182/bloodadvances.2022007359. Blood Adv. 2022. PMID: 35709473 Free PMC article.
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.
Albanell J, Pérez-García JM, Gil-Gil M, Curigliano G, Ruíz-Borrego M, Comerma L, Gibert J, Bellet M, Bermejo B, Calvo L, de la Haba J, Espinosa E, Minisini AM, Quiroga V, Santaballa Bertran A, Mina L, Bellosillo B, Rojo F, Menéndez S, Sampayo-Cordero M, Popa C, Malfettone A, Cortés J, Llombart-Cussac A. Albanell J, et al. Among authors: gibert j. Clin Cancer Res. 2023 Jan 4;29(1):67-80. doi: 10.1158/1078-0432.CCR-22-1281. Clin Cancer Res. 2023. PMID: 36165912 Free PMC article. Clinical Trial.
163 results